These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 7521428
1. [Histological assessment of the liver long after interferon treatment in patients with chronic type C hepatitis]. Yokosuka O, Hosoda K, Omata M. Nihon Rinsho; 1994 Jul; 52(7):1841-6. PubMed ID: 7521428 [Abstract] [Full Text] [Related]
2. [The indication and the evaluation of IFN treatment of chronic hepatitis C]. Yano M. Nihon Rinsho; 1994 Jul; 52(7):1778-83. PubMed ID: 7521417 [Abstract] [Full Text] [Related]
3. Retreatment of chronic hepatitis C with interferon. Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, Suga T, Ohki H, Ito O. Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572 [Abstract] [Full Text] [Related]
4. Therapy of hepatitis C: patients with normal aminotransferase levels. Marcellin P, Lévy S, Erlinger S. Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678 [Abstract] [Full Text] [Related]
9. [Clinical study of retreatment of chronic hepatitis C with interferon (IFN) for non-complete responders on initial treatment]. Toyoda H, Nakano S, Kumada T. Nihon Rinsho; 1994 Jul; 52(7):1798-803. PubMed ID: 7521421 [Abstract] [Full Text] [Related]
10. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. Trabaud MA, Bailly F, Si-Ahmed SN, Chevallier P, Sepetjan M, Colucci G, Trépo C. J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466 [Abstract] [Full Text] [Related]
11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. Hepatogastroenterology; 1997 May; 44(14):417-25. PubMed ID: 9164512 [Abstract] [Full Text] [Related]
12. [Correlation between histological features of liver biopsy specimens and clinical effect of interferon on patients with chronic hepatitis C]. Kumagai N, Kuramochi S. Nihon Rinsho; 1994 Jul; 52(7):1769-73. PubMed ID: 7521416 [Abstract] [Full Text] [Related]
13. [Autoimmune hepatitis with hepatitis C virus markers (anti HCV antibody or HCV-RNA) and interferon therapy]. Kaji K, Unoura M, Kobayashi K, Nakanuma Y. Nihon Rinsho; 1994 Jul; 52(7):1865-8. PubMed ID: 7521432 [Abstract] [Full Text] [Related]
14. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209 [Abstract] [Full Text] [Related]
16. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy. Akiyoshi F, Sata M, Uchimura Y, Suzuki H, Tanikawa K. Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063 [Abstract] [Full Text] [Related]
18. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. Hepatology; 1997 Mar; 25(3):697-701. PubMed ID: 9049221 [Abstract] [Full Text] [Related]